GSK is expected to report earnings to rise 102.54% to $1.37 per share on October 28
Q3'26
Est.
$1.37
Q2'26
Beat
by $0.21
Q1'26
Missed
by $0.54
Q4'25
Beat
by $0.06
Q3'25
Beat
by $0.20
The last earnings report on July 28 showed earnings per share of 67 cents, beating the estimate of 46 cents. With 2.41M shares outstanding, the current market capitalization sits at 97.51B.